In March 2019, Dermapharm Holding SE ( FRA:DMP ) announced its earnings update. Overall, it seems that analyst forecasts are fairly optimistic, with profits predicted to increase by 37% next year compared with the past 5-year average growth rate of 30%. Currently with trailing-twelve-month earnings of €75m, we can expect this to reach €103m by 2020. Below is a brief commentary on the longer term outlook the market has for Dermapharm Holding. For those interested in more of an analysis of the company, you can research its fundamentals here.